SG48492A1 - Long-lasting release nifedipine preparation - Google Patents
Long-lasting release nifedipine preparationInfo
- Publication number
- SG48492A1 SG48492A1 SG1996011422A SG1996011422A SG48492A1 SG 48492 A1 SG48492 A1 SG 48492A1 SG 1996011422 A SG1996011422 A SG 1996011422A SG 1996011422 A SG1996011422 A SG 1996011422A SG 48492 A1 SG48492 A1 SG 48492A1
- Authority
- SG
- Singapore
- Prior art keywords
- hours
- long
- nifedipine
- lasting release
- dissolution test
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33121795A JP3220373B2 (ja) | 1995-11-28 | 1995-11-28 | 持続性ニフエジピン製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG48492A1 true SG48492A1 (en) | 1998-04-17 |
Family
ID=18241212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG1996011422A SG48492A1 (en) | 1995-11-28 | 1996-11-25 | Long-lasting release nifedipine preparation |
Country Status (14)
Country | Link |
---|---|
US (1) | US5861173A (xx) |
EP (1) | EP0776660B1 (xx) |
JP (1) | JP3220373B2 (xx) |
KR (1) | KR970025607A (xx) |
AT (1) | ATE220898T1 (xx) |
AU (1) | AU709887B2 (xx) |
CA (1) | CA2191178C (xx) |
DE (1) | DE69622510T2 (xx) |
ES (1) | ES2180683T3 (xx) |
IL (1) | IL119684A (xx) |
MX (1) | MX9605646A (xx) |
NZ (1) | NZ299818A (xx) |
SG (1) | SG48492A1 (xx) |
ZA (1) | ZA969945B (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN190974B (xx) * | 1999-09-10 | 2003-09-06 | Ranbaxy Lab Ltd | |
ES2270982T3 (es) | 2000-02-04 | 2007-04-16 | Depomed, Inc. | Forma de dosificacion de nucleo y carcasa que se aproxima a una liberacion del farmaco de orden cero. |
JP4637338B2 (ja) * | 2000-09-22 | 2011-02-23 | 大塚製薬株式会社 | シロスタゾール有核錠 |
SE0004671D0 (sv) | 2000-12-15 | 2000-12-15 | Amarin Dev Ab | Pharmaceutical formulation |
KR100685945B1 (ko) | 2000-12-29 | 2007-02-23 | 엘지.필립스 엘시디 주식회사 | 액정표시장치 및 그 제조방법 |
US20050175687A1 (en) * | 2001-01-30 | 2005-08-11 | Mcallister Stephen M. | Pharmaceutical formulations |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
US7883721B2 (en) | 2001-01-30 | 2011-02-08 | Smithkline Beecham Limited | Pharmaceutical formulation |
US6987123B2 (en) | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
JP4817562B2 (ja) * | 2001-09-26 | 2011-11-16 | 東和薬品株式会社 | 長時間持続型ニフエジピン有核錠 |
WO2003026625A1 (en) * | 2001-09-28 | 2003-04-03 | Mcneil-Ppc, Inc. | Modified release dosage forms |
US20030104052A1 (en) * | 2001-10-25 | 2003-06-05 | Bret Berner | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
CA2409552A1 (en) | 2001-10-25 | 2003-04-25 | Depomed, Inc. | Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
US20030152622A1 (en) * | 2001-10-25 | 2003-08-14 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral diuretic |
US6682759B2 (en) | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
AU2003227472A1 (en) * | 2002-03-27 | 2003-10-08 | Bayer Aktiengesellschaft | Downsized core tablet containing nifedipine |
EP1364644B1 (en) * | 2002-05-21 | 2008-09-17 | Watson Laboratories, Inc. | Pharmaceutical formulation with extended release |
JP4563642B2 (ja) * | 2002-05-31 | 2010-10-13 | ワトソン ラボラトリーズ、インコーポレイテッド | 医薬製剤 |
JP4933033B2 (ja) * | 2003-03-17 | 2012-05-16 | 武田薬品工業株式会社 | 放出制御組成物 |
WO2004082665A1 (ja) * | 2003-03-17 | 2004-09-30 | Takeda Pharmaceutical Company Limited | 放出制御組成物 |
PL1631251T3 (pl) | 2003-04-24 | 2011-12-30 | Jagotec Ag | Tabletka o opóźnionym uwalnianiu i o określonej geometrii |
US20040219210A1 (en) * | 2003-05-01 | 2004-11-04 | Jian-Hwa Guo | Controlled release solid dosage nifedipine formulations |
US20040241234A1 (en) * | 2003-06-02 | 2004-12-02 | Alpharma, Inc. | Controlled release press-coated formulations of water-soluble active agents |
US20050013863A1 (en) | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
TW200526274A (en) | 2003-07-21 | 2005-08-16 | Smithkline Beecham Plc | Pharmaceutical formulations |
US20060024368A1 (en) * | 2004-07-30 | 2006-02-02 | Reza Fassihi | Compressed composite delivery system for release-rate modulation of bioactives |
US7470293B2 (en) * | 2004-10-29 | 2008-12-30 | Idatech, Llc | Feedstock delivery systems, fuel processing systems, and hydrogen generation assemblies including the same |
US8673352B2 (en) * | 2005-04-15 | 2014-03-18 | Mcneil-Ppc, Inc. | Modified release dosage form |
DE102005031577A1 (de) | 2005-07-06 | 2007-01-11 | Bayer Healthcare Ag | Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten |
US8637078B2 (en) * | 2005-11-24 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Bilayer tablet comprising telmisartan and diuretic |
KR100774250B1 (ko) | 2006-04-14 | 2007-11-07 | 넨시스(주) | 1,4-디히드로피리딘 유도체 용출 제어형 과립제, 이의 정제및 이의 제조방법 |
WO2008015018A1 (en) | 2006-08-03 | 2008-02-07 | Nitec Pharma Ag | Delayed-release glucocorticoid treatment of rheumatoid disease |
HUE034657T2 (en) * | 2007-06-11 | 2018-03-28 | Procter & Gamble | Carrier granules with a beneficial additive |
WO2009028598A1 (ja) | 2007-08-31 | 2009-03-05 | Daiichi Sankyo Company, Limited | 徐放性製剤及びその製造方法 |
US20100316711A1 (en) * | 2007-10-25 | 2010-12-16 | Bayer Yakuhin ,Ltd. | Nifedipine containing opress coated tablet and method of preparing same |
WO2009140527A1 (en) * | 2008-05-14 | 2009-11-19 | Capricorn Pharma, Inc. | Modified release formulations of dihydropyridine compounds and methods of making same |
DE102008059206A1 (de) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
JP5669837B2 (ja) * | 2010-06-16 | 2015-02-18 | 帝人ファーマ株式会社 | 放出制御型の有核錠剤 |
WO2015186693A1 (ja) * | 2014-06-02 | 2015-12-10 | ニプロ株式会社 | レーザー印刷用錠剤及びその製造方法 |
WO2016128972A1 (en) * | 2015-02-09 | 2016-08-18 | Entera Bio Ltd. | Formulations for oral administration of active agents with controlled absorption profile |
WO2017111178A1 (en) | 2015-12-24 | 2017-06-29 | Takeda Pharmaceutical Company Limited | Solid preparation |
CN115192538B (zh) * | 2022-08-02 | 2023-09-15 | 沈阳信康药物研究有限公司 | 一种压制包衣型硝苯地平缓释片及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3033919A1 (de) | 1980-09-09 | 1982-04-22 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung |
DE3720757A1 (de) | 1987-06-24 | 1989-01-05 | Bayer Ag | Dhp-manteltablette |
NO883326L (no) * | 1987-08-11 | 1989-02-13 | Bayer Ag | Dhp-retard-tilberedning. |
DE3814532A1 (de) * | 1988-04-29 | 1989-11-09 | Bayer Ag | Dhp-retard-zubereitung |
HU203041B (en) * | 1989-03-14 | 1991-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin |
-
1995
- 1995-11-28 JP JP33121795A patent/JP3220373B2/ja not_active Expired - Lifetime
-
1996
- 1996-11-15 AT AT96118311T patent/ATE220898T1/de not_active IP Right Cessation
- 1996-11-15 DE DE69622510T patent/DE69622510T2/de not_active Expired - Lifetime
- 1996-11-15 ES ES96118311T patent/ES2180683T3/es not_active Expired - Lifetime
- 1996-11-15 EP EP96118311A patent/EP0776660B1/en not_active Expired - Lifetime
- 1996-11-18 MX MX9605646A patent/MX9605646A/es unknown
- 1996-11-21 US US08/755,381 patent/US5861173A/en not_active Expired - Lifetime
- 1996-11-25 SG SG1996011422A patent/SG48492A1/en unknown
- 1996-11-25 NZ NZ299818A patent/NZ299818A/en unknown
- 1996-11-25 AU AU71960/96A patent/AU709887B2/en not_active Ceased
- 1996-11-25 IL IL11968496A patent/IL119684A/xx not_active IP Right Cessation
- 1996-11-25 CA CA002191178A patent/CA2191178C/en not_active Expired - Fee Related
- 1996-11-27 ZA ZA969945A patent/ZA969945B/xx unknown
- 1996-11-27 KR KR1019960058350A patent/KR970025607A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2191178C (en) | 2005-10-04 |
NZ299818A (en) | 1998-08-26 |
ZA969945B (en) | 1997-06-23 |
DE69622510T2 (de) | 2002-11-07 |
AU709887B2 (en) | 1999-09-09 |
EP0776660B1 (en) | 2002-07-24 |
ES2180683T3 (es) | 2003-02-16 |
AU7196096A (en) | 1997-06-05 |
JP3220373B2 (ja) | 2001-10-22 |
ATE220898T1 (de) | 2002-08-15 |
US5861173A (en) | 1999-01-19 |
DE69622510D1 (de) | 2002-08-29 |
IL119684A (en) | 2000-09-28 |
JPH09143073A (ja) | 1997-06-03 |
EP0776660A2 (en) | 1997-06-04 |
EP0776660A3 (en) | 1998-01-21 |
IL119684A0 (en) | 1997-02-18 |
KR970025607A (ko) | 1997-06-24 |
MX9605646A (es) | 1997-06-28 |
CA2191178A1 (en) | 1997-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG48492A1 (en) | Long-lasting release nifedipine preparation | |
CA2232450A1 (en) | Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole | |
DE3887179D1 (de) | Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung. | |
IL211075A (en) | Multi-component preparation with irregular release | |
CA2265766A1 (en) | Rapidly disintegrating pellets | |
BG103740A (en) | Phytostyrene composition for the prevention of the alzheimer's disease | |
PL356962A1 (en) | Multi-particulate form of medicament, comprising at least two differently coated forms of pellet | |
CA2346001A1 (en) | Controlled release nanoparticulate compositions | |
GB8626098D0 (en) | Controlled release hydromorphone composition | |
DE69425932D1 (de) | Schnellauflösliche pharmazeutische Dosierungsformen und Verfahren zu ihrer Herstellung | |
IE882921L (en) | "new pharmaceutical preparation and process for its preparation" | |
HK1036417A1 (en) | A non-stustained release, non-chewable pharmaceutical tablet composition | |
MY139606A (en) | Sustained-release composition and process for producing the same | |
DE59908764D1 (de) | Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung | |
YU19301A (sh) | Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze | |
BG106927A (en) | Matrix tablet for prolonged release of trimetazidine after oral administration | |
HK1043945A1 (en) | Pharmaceutical capsule compositions containing loratadine and pseudoephedrine. | |
CA2283255A1 (en) | Use of r-nsaid's for the prevention of alzheimer's disease | |
CA2240281A1 (en) | Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases | |
ATE143010T1 (de) | Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
PL299376A1 (en) | Method of making solid dosage units of controllable release | |
IT1252185B (it) | Preparazioni farmaceutiche a liberazione programmata | |
ATE285252T1 (de) | Mittel zur verhinderung der truebung der vorderen linsenkapsel | |
GR3018795T3 (en) | Emulsion-free emulsion polymers in sustained-release pharmaceutical compositions and their production | |
TH43680A (th) | เกลือเชอร์ทราลีนและรูปแบบการใช้ที่มีการหน่วงการปลดปล่อยของเซอร์ทราลีน |